Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.49 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.49 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.47 |
| ▸ | CTSC | P53634 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | KLK7 | P49862 | 1/20 | 0.44 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23039359 | 1.00 | CA1 (0.51) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL29482151 | 1.00 | CA1 (0.51) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL22127908 | 1.00 | CA1 (0.51) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL23039364 | 0.97 | CA1 (0.55) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL23039366 | 0.97 | CA1 (0.55) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL23039363 | 0.97 | CA1 (0.55) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL22127970 | 0.92 | FOLH1 (0.56) | SIRT2SIRT1HTR2CHTR2BFOLH1 | |
| SCHEMBL22127969 | 0.92 | FOLH1 (0.56) | SIRT2SIRT1HTR2CHTR2BFOLH1 | |
| SCHEMBL22127992 | 0.92 | CA2 (0.46) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL22127827 | 0.92 | CA2 (0.46) | CA1CA2SIRT2SIRT1SIRT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115475229-A | Preparation and use of active oxygen scavenger | 凯瑞康宁生物工程（武汉）有限公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-111356699-B | Preparation and use of active oxygen scavenger | 凯瑞康宁生物工程（武汉）有限公司 | 2022-08-23 | — | — | CN | disclosed |
| EP-3988561-A1 | PREPARATION AND USE OF REACTIVE OXYGEN SPECIES SCAVENGER | XWPharma Ltd. (KY) | 2022-04-27 | — | — | EP | disclosed |
| US-11312703-B2 | Reactive oxygen species scavengers and use for treating diseases | XWPharma Ltd. (KY) | 2022-04-26 | — | — | US | disclosed |
| EP-3679051-B1 | PREPARATION AND USE OF REACTIVE OXYGEN SPECIES SCAVENGER | XWPHARMA LTD (KY) | 2021-12-29 | — | — | EP | disclosed |
| US-20210061791-A1 | REACTIVE OXYGEN SPECIES SCAVENGERS AND USE FOR TREATING DISEASES | XWPharma Ltd. (KY) | 2021-03-04 | — | — | US | disclosed |
| CN-111356699-A | Preparation and use of active oxygen scavenger | 凯瑞康宁生物工程（武汉）有限公司 | 2020-06-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210061791-A1 | REACTIVE OXYGEN SPECIES SCAVENGERS AND USE FOR TREATING DISEASES | GSR, TXNRD2, GPX1 | CA1 2491/4885CA2 1418/4885SIRT2 1528/4885 |
| US-11312703-B2 | Reactive oxygen species scavengers and use for treating diseases | GSR, TXNRD2, GPX1 | CA1 2491/4885CA2 1418/4885SIRT2 1528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.